Topics

  • ONE TIME EVENT

    Advancing mCRC Treatment: Integrating Biomarker Testing, ESMO 2022 Guidelines, and Anti-eGFR Therapies

  • ONE TIME EVENT

    Chance for Cure in CD30+ Lymphomas: Improving Outcomes in HL

  • ONE TIME EVENT

    mCRC Boot Camp for Oncologists

  • ONE TIME EVENT

    Narrowing the Gap in DLBCL: Updates in new treatment options

  • ONE TIME EVENT

    Brentuximab Vedotin: Finding a Chance for Cure in Peripheral T-cell Lymphoma and other CD30+ Lymphomas